• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽 - 主要组织相容性复合体复合物与T细胞受体的低亲和力相互作用。

Low affinity interaction of peptide-MHC complexes with T cell receptors.

作者信息

Matsui K, Boniface J J, Reay P A, Schild H, Fazekas de St Groth B, Davis M M

机构信息

Howard Hughes Medical Institute, Stanford, CA.

出版信息

Science. 1991 Dec 20;254(5039):1788-91. doi: 10.1126/science.1763329.

DOI:10.1126/science.1763329
PMID:1763329
Abstract

The interaction of antigen-specific T cell receptors (TCRs) with their ligands, peptides bound to molecules of the major histocompatibility complex (MHC), is central to most immune responses, yet little is known about its chemical characteristics. The binding to T cells of a labeled monoclonal antibody to the TCR was inhibited by soluble class II MHC heterodimers complexed to different peptides. Inhibition was both peptide- and TCR-specific and of low affinity, with a KD = 4 x 10(-5) to 6 x 10(-5) M, orders of magnitude weaker than comparable antibody-antigen interactions. This finding is consistent with the scanning nature of T cell recognition and suggests that antigen-independent adhesion precedes TCR engagement.

摘要

抗原特异性T细胞受体(TCRs)与其配体(即与主要组织相容性复合体(MHC)分子结合的肽段)之间的相互作用是大多数免疫反应的核心,但对其化学特性却知之甚少。与不同肽段复合的可溶性II类MHC异二聚体可抑制标记的抗TCR单克隆抗体与T细胞的结合。抑制作用具有肽段特异性和TCR特异性,且亲和力较低,解离常数(KD)为4×10⁻⁵至6×10⁻⁵ M,比类似的抗体 - 抗原相互作用弱几个数量级。这一发现与T细胞识别的扫描性质一致,并表明在TCR参与之前存在抗原非依赖性黏附。

相似文献

1
Low affinity interaction of peptide-MHC complexes with T cell receptors.肽 - 主要组织相容性复合体复合物与T细胞受体的低亲和力相互作用。
Science. 1991 Dec 20;254(5039):1788-91. doi: 10.1126/science.1763329.
2
Cloned T cells internalize peptide from bound complexes of peptide and purified class II major histocompatibility complex antigen.克隆化的T细胞从肽与纯化的II类主要组织相容性复合体抗原的结合复合物中内化肽。
J Biol Chem. 1993 Jul 5;268(19):14360-6.
3
T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.T细胞受体与肽/主要组织相容性复合体(MHC)以及超抗原/MHC配体的相互作用主要由抗原主导。
J Exp Med. 1993 Aug 1;178(2):713-22. doi: 10.1084/jem.178.2.713.
4
Molecular components of T-cell recognition.T细胞识别的分子成分。
Annu Rev Immunol. 1992;10:835-73. doi: 10.1146/annurev.iy.10.040192.004155.
5
T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.T细胞对主要组织相容性复合体II类复合物与恒定链加工中间体的识别。
J Exp Med. 1995 Nov 1;182(5):1403-13. doi: 10.1084/jem.182.5.1403.
6
Interactions of TCRs with MHC-peptide complexes: a quantitative basis for mechanistic models.TCR与MHC-肽复合物的相互作用:机制模型的定量基础。
Curr Opin Immunol. 1997 Jun;9(3):390-5. doi: 10.1016/s0952-7915(97)80086-6.
7
Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.MHC II类多态性残基的功能图谱。α链控制结合Ad与Ak限制性肽的特异性,β链的65-67区域控制T细胞识别,但不控制肽结合。
J Immunol. 1991 May 1;146(9):2952-9.
8
Major histocompatibility complex determinants select T-cell receptor alpha chain variable region dominance in a peptide-specific response.主要组织相容性复合体决定因素在肽特异性应答中选择T细胞受体α链可变区优势。
Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):8874-8. doi: 10.1073/pnas.89.19.8874.
9
Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness.T细胞受体与肽/I-Ek复合物结合的动力学:解离速率与T细胞反应性的相关性。
Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12862-6. doi: 10.1073/pnas.91.26.12862.
10
Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.利用鸽细胞色素c特异性T细胞杂交瘤分析不同主要组织相容性复合体/T细胞受体复合物中的肽结合模式。单一肽以不同构象结合主要组织相容性复合体的证据。
J Exp Med. 1989 Nov 1;170(5):1609-25. doi: 10.1084/jem.170.5.1609.

引用本文的文献

1
Transferrin Disassociates TCR from CD3 Signaling Apparatus to Promote Metastasis.转铁蛋白使TCR与CD3信号装置解离以促进转移。
Research (Wash D C). 2025 Jan 13;8:0578. doi: 10.34133/research.0578. eCollection 2025.
2
CRISPR-Cas9 screening reveals a distinct class of MHC-I binders with precise HLA-peptide recognition.CRISPR-Cas9筛选揭示了一类具有精确HLA-肽识别能力的独特MHC-I结合物。
iScience. 2024 May 27;27(6):110120. doi: 10.1016/j.isci.2024.110120. eCollection 2024 Jun 21.
3
Monomeric agonist peptide/MHCII complexes activate T-cells in an autonomous fashion.
单体激动肽/MHCII 复合物以自主方式激活 T 细胞。
EMBO Rep. 2023 Nov 6;24(11):e57842. doi: 10.15252/embr.202357842. Epub 2023 Sep 28.
4
Factors contributing to the potency of CD8 T cells.导致 CD8 T 细胞效力的因素。
Trends Immunol. 2023 Sep;44(9):693-700. doi: 10.1016/j.it.2023.07.005. Epub 2023 Aug 7.
5
The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells.自然杀伤细胞受体 NKp46 识别内质网应激细胞表面的外钙网素。
Nature. 2023 Apr;616(7956):348-356. doi: 10.1038/s41586-023-05912-0. Epub 2023 Apr 5.
6
Engineering second-generation TCR-T cells by site-specific integration of TRAF-binding motifs into the locus.通过将 TRAF 结合基序特异性整合到 基因座中来工程第二代 TCR-T 细胞。
J Immunother Cancer. 2023 Apr;11(4). doi: 10.1136/jitc-2022-005519.
7
T-cell antigen recognition: catch-as-catch-can or catch-22?T 细胞抗原识别:投机取巧还是进退维谷?
EMBO J. 2023 Apr 3;42(7):e113507. doi: 10.15252/embj.2023113507. Epub 2023 Feb 20.
8
MHC-independent αβT cells: Lessons learned about thymic selection and MHC-restriction.MHC 非依赖的 αβT 细胞:胸腺选择和 MHC 限制方面的经验教训。
Front Immunol. 2022 Jul 14;13:953160. doi: 10.3389/fimmu.2022.953160. eCollection 2022.
9
Mammalian Display Platform for the Maturation of Bispecific TCR-Based Molecules.用于基于双特异性TCR分子成熟的哺乳动物展示平台。
Antibodies (Basel). 2022 May 10;11(2):34. doi: 10.3390/antib11020034.
10
Regulating the discriminatory response to antigen by T-cell receptor.通过T细胞受体调节对抗原的特异性反应。
Biosci Rep. 2022 Mar 31;42(3). doi: 10.1042/BSR20212012.